Scientific Industries, Inc. · OTC:SCND
Scientific Industries — Investor Presentation (December 2021)
23 slides from Scientific Industries's investor presentation, December 2021
Slide 1: Scientific Industries, Inc. (SCND-OTCQB) Investor Presentation
SCIENTIFIC INDUSTRIES, INC. (SCND-OTCQB) INVESTOR PRESENTATION December 2021
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements within the meaning of the federal securities laws. All statements, other than statements of historical facts, included in this presentation that address activities, events or developments that Scientific Industries, Inc. and its subsid
Slide 3: Agenda
Agenda Company Overview Financial Overview Expansion of Bioprocessing business 3
Slide 4: Unique opportunity to invest into a growing life science tool franchise
Unique opportunity to invest into a growing life science tool franchise and a future leader for online & real-time bioprocessing sensorics (SBI/aquila) § Scientific Industries, Inc (SI) has a profitable and growing base life sciences tools business and is acknowledged world leader in vortexing techn
Slide 5: SI has several brands and daughter companies focusing on specific technologies
SI has several brands and daughter companies focusing on specific technologies and customer segments Key Product Offerings § World Leader in § Pill-counters and § Bioprocessing optical sensors and Vortexing Technologies Balances automated feeding § 2014 acquisition of § 2021 launch of SBI/aquila bio
Slide 6: Scientific Industries has a growing base of life sciences tools businesses
Scientific Industries, Inc (SI), has a growing base of life sciences tools businesses and is acknowledged world leader in vortexing technologies Scientific Industries, Inc. (est. 1954) § Design, manufacturing, and marketing of benchtop laboratory equipment § Installed base of over 1,000,000 units wo
Slide 7: A shift to large molecule drugs creates demand for continuous monitoring sensors
A shift to large molecule drugs in pharmaceutical production creates demand for effective continuous monitoring sensors and software Bioprocessing Industry Challenges § From small molecule to large molecule drugs (7 out of 10 of the top 10 selling drugs are biologicals) § Small molecules typically h
Slide 8: Bioprocessing industry suffering from poor reproducibility and high COGS
The bioprocessing and cell culture industry is currently suffering from poor reproducibility, unpredictable scale up, manual processes and high COGS Current State 8
Slide 9: SBI vision and mission for bioprocessing monitoring
SBI is poised to revolutionize bioprocessing and wants to become the market leader for non-invasive online and real-time monitoring for bioprocessing applications Vision & Mission SBI VISION We pioneer digitally simplified bioprocessing by providing actionable insights from lab to production floor.
Slide 10: SBI will provide solutions for reproducibility, scale up and lower COGS
SBI will provide solutions and help create high reproducibility, predictable scale up, automated processes and lower COGS for the bioprocessing industry Future State 10
Slide 11: Digitally Simplified Bioprocessing from lab to production floor
We pioneer Digitally Simplified Bioprocessing from the lab to the production floor. Digitally Simplified Bioprocessing Digitally Simplified Bioprocessing Digitally Simplified Bioprocessing § Miniaturized Smart Sensors § Actionable Insights § From Lab to Production Floor § IoT § Non-invasively and in
Slide 12: SBI's Key Upcoming Technological Milestones
SBI’s goal is to become the one-stop-shop provider for almost any monitoring and bioprocess control modality. SBI‘s Key Upcoming Technological Milestones Q2 – Acquisition of Q1 – Integration of pH Q2 – Launch of new Q4 – Launch of new aquila biolabs and DO sensors sensor platform COCO COCO readers 2
Slide 13: Key Product Offerings
Key Biomass in Shake Flasks Biomass in Bioreactors Product Offerings § Historical revenue streams for Scientific Bioprocessing have been derived from C royalties received from product Cell Growth Quantifier (CGQ) Cell Growth Quantifier (CGQBioR) manufacturers in the bioprocessing industry which use
Slide 14: How do we drive adoption of Digitally Simplified Bioprocessing?
How do we drive adoption of Digitally Simplified Bioprocessing? Direct Sales Team Spearheading Market Penetration Direct Sales Team James "Bucky" Polk Vice President of Global Sales Original Equipment Manufacturer Accounts Manufacturing Institutes 14
Slide 15: Total Available Market of > $1Bn for SI
Total Available Market of > $1Bn for SI – SBI targeting market segments with strongest growth: Bioprocessing, Single use Bioprocessing and Cell Culture Key Market Insight Benchtop Laboratory Equipment § Laboratory Equipment market is a highly competitive and mature industry Vortex § Market drivers i
Slide 16: Agenda
Agenda Company Overview Financial Overview Expansion of SBI with aquila biolabs 16
Slide 17: Financial Overview
Financial Overview § Scientific Industries, Inc., (“SCND”) established in 1954, designs, manufactures, and markets benchtop laboratory equipment, and through its Bioprocessing Systems Operations (“SBI”) is engaged in Shares Outstanding 6.46 MILLION the development and marketing of non-invasive, real
Slide 18: SI is a profitable company with two business platforms
Scientific Industries, Inc (SI) is a profitable company with two established and powerful business platforms of bioprocessing and laboratory product Revenue Breakdown lines § $0.7 million of 2021 Revenues, majority derived from 3rd party § $9.0 million of 2021 Revenues derived from royalty payments
Slide 19: Agenda
Agenda Company Overview Financial Overview Expansion of SBI with aquila biolabs 19
Slide 20: aquila biolabs provides online and real-time smart sensors
aquila biolabs is a provider for online and real-time smart sensors, actuators and data analytics for bioprocessing aquila biolabs Today Tomorrow Provide online and real-time smart sensors, actuators Pioneer the first miniaturized smart sensor IoT and data analytics for bioprocessing platform for bi
Slide 21: The acquisition of aquila biolabs enabled SBI to capture synergies
The acquisition of aquila biolabs enabled SBI to capture synergies on all relevant levels and position itself for a future leading role in the bioprocessing space Synergies Required for success SBI aquila Combined Software, Data Analytics, Soft Sensors Miniaturized Sensor Hardware Sensor Chemistry A
Slide 22: SBI and aquila biolabs create solutions through an IoT sensing platform
SBI and aquila biolabs together create solutions to urgent life science industry challenges through a comprehensive IoT sensing and control platform An Ideal Merger Formula 1 2 3 Quick Wins Value Added Solutions Leadership Position + + Reducing COGS by Minimize Batch-to- Improving Increasing speed t
Slide 23: Seasoned Leadership Team for SI and SBI
Seasoned Leadership Team With Track Record of Proven Success in Executive Roles in place for SI and SBI Leadership Team Leadership Team Helena Santos John Moore CEO, CFO & Director Chairman & President – SBI Reinhard Vogt Non-Management Directors Director & Chairman – SBI Marcus Frampton Chris Cox J
Scientific Industries — Investor Presentation (December 2021) on 6ix